Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis

INTRODUCTION: In immune-mediated inflammatory diseases, there is a lack of -estimates of glucocorticoid dose–response diabetes risk that consider changes in prescribed dose over time and disease activity. RESEARCH DESIGN AND METHODS: Population-based longitudinal analysis of electronic health record...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianhua, Mackie, Sarah L, Pujades-Rodriguez, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389515/
https://www.ncbi.nlm.nih.gov/pubmed/32719077
http://dx.doi.org/10.1136/bmjdrc-2020-001220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389515/
https://www.ncbi.nlm.nih.gov/pubmed/32719077
http://dx.doi.org/10.1136/bmjdrc-2020-001220

Ejemplares similares